Avaliação de pacientes egressos de um serviço de cuidado farmacêutico para hipertensão e diabetes

Abstract

Systematic Hypertension and Diabetes Mellitus are non-communicable and chronic diseases that affect a significant portion of the world population. Systematic Hypertension is characterized by the presence of blood pressure equal or higher than 140/90 mm Hg, while Diabetes Mellitus is characterized by the emergence of metabolic disorders, particularly hyperglycemia. This study sined to evaluate the maintenance of the clinical benefits of a therapeutic monitoring in patients discharged from the Pharmaceutical Care Unit Dr. Anastácio Magalhães. This care unit is located in Fortaleza, Ceará - Brazil. Two patient groups were analyzed by this study: hypertensive patients and/ or diabetic patients who have already completed the pharmacotherapy care plan for at least 6 months and those patients who did not complete the pharmacotherapy plan. The observational and cross-sectional study was conducted in two phases. In the retrospective phase we used the "Instrument of Measure of Accession to the Treatment", the register of pharmacotherapeutic records and laboratory tests obtained during the Pharmacotherapy Monitoring Questionnaire (AFT). The same methods were used at the prospective phase, but the data were collected at the time of post consultation. At the end of data collection we obtained a sample of 109 patients. The differences between the results obtained for each group during the study were compared. After statistical analysis, it was observed that the average systolic blood pressure (PAS) for patients who completed the AFT was equivalent to 126,59 and the average blood pressure obtained at the post consultation was equal to 125,31 (p = 0,613). In contrast, patients who did not complete the AFT showed a decrease in average systolic blood pressure, but did not reach values as close to the therapeutic goal as the first group. For patients who completed the AFT, mean diastolic blood pressure (PAD) at the end of the AFT was 78.18 and average PAD obtained at the post consultation was equal to 78.68 (P = 0.784). For patients who did not complete the AFT, the last average PAD in AFT was 83.33 and the average obtained at the post return was equal to 79.399 (p = 0.151). The average blood glucose found in the last consultation for patients who completed the AFT was 107.23 and the average obtained in the post consultation was equal to 117.42 (p = 0.133). For patients who did not finalize the AFT, average blood glucose obtained in the last consultation was equal to 133.18 and the average obtained in thepost monitoring visit was equivalent to 157.933, (p = 0.152). The average measured adherence for patients who completed the AFT at the time of the last consultation was equivalent to 37.00 and at the post consultation was equal to 38.35 (p = 0.10). The average of patients who did not finalize the AFT in the last visit was equal to 36.80 and post consultation was equal to 36.13 (p = 0.42). The results show that patients who completed the AFT showed better clinical indicators and these indicators showed a greater tendency to be held closer to therapeutic target due to the monitoring end time.